All Insurance Policy Changes (Page 122)

Continuing from page 121. Showing older policy changes tracked across all payers. Use the filters in the related-hubs section below to narrow by provider, state, or specialty.

High impact
Tzield® (Teplizumab-Mzwv)
UnitedHealthcare·Identified Jul 2, 2026
Unable to extract policy details. The provided PDF content is encoded/corrupted and does not display readable policy text regarding Tzield® (Teplizumab-Mzwv). The document appears to be a valid UHC medical policy file based on the source URL (July 2026 bulletin), but the actual policy requirements, effective dates, billing codes, and coverage criteria are not legible in the provided stream.
Medium impact
Synagis ® (Palivizumab)
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Scenesse® (Afamelanotide)
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Saphnelo® (Anifrolumab-Fnia)
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
High impact
Kebilidi® (Eladocagene Exuparvovec-Tneq)
UnitedHealthcare·Identified Jul 2, 2026
Unable to extract actionable policy information from this document. The provided PDF content appears corrupted or improperly encoded, containing only binary/compressed data streams without readable policy text. The billing team cannot implement changes without access to the actual Kebilidi® policy details.
Medium impact
Itvisma® (Onasemnogene Abeparvovec-Brve)
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Intracanalicular and Intravitreal Corticosteroid Implants
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
High impact
Clotting Factors, Coagulant Blood Products, & Other Hemostatics
UnitedHealthcare·Effective Sep 1, 2026
Unable to provide complete analysis. The policy document content was not included in the provided information—only metadata and a URL reference were supplied. The billing team cannot implement changes without access to the actual policy text detailing coverage criteria, prior authorization requirements, billing codes, or reimbursement changes for clotting factors and hemostatics.
Medium impact
Adzynma (ADAMTS13, Recombinant-Krhn)
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Surgery of the Wrist or Thumb
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Surgery of the Elbow
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Spinal Fusion and Decompression
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Skin and Soft Tissue Substitutes
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Sinus Surgeries and Interventions
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Screening Colonoscopy Procedures – Site of Service
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Outpatient Surgical Procedures – Site of Service
UnitedHealthcare·Identified Jul 2, 2026
Unable to extract policy content. The provided PDF appears to be corrupted or improperly encoded, containing only binary/stream data without readable text. The policy title indicates changes to outpatient surgical procedures and site of service requirements, but specific details, effective dates, affected codes, and requirements cannot be determined from the source material.
High impact
Molecular Oncology Testing for Solid Tumor Cancer Diagnosis, Prognosis, and Treatment Decisions
UnitedHealthcare·Effective Aug 1, 2026
Unable to provide complete analysis. The policy document content was not fully provided in the source material. While the metadata indicates this is a revised medical policy effective 2026-08-01 regarding Molecular Oncology Testing for solid tumor cancer diagnosis, prognosis, and treatment decisions, the actual policy details (coverage criteria, billing codes, prior authorization requirements, and specific clinical guidelines) are not included in the analysis request. A complete policy review requires access to the full document text.
Medium impact
Gender Dysphoria Treatment
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Cognitive Rehabilitation and Coma Stimulation
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Brow Ptosis and Eyelid Repair
UnitedHealthcare·Identified Jul 2, 2026
Failed to analyze policy change
Medium impact
Physical and Occupational Therapy Coverage for Adults in a Clinic Setting
Arkansas Medicaid·Identified Jul 2, 2026
Failed to analyze policy change
High impact
Special Alert August 2025 - Benign Skin Lesion Removal Billing Guidelines
Providence Health Plan·Effective Aug 1, 2025
Providence Health Plan issued a critical billing update for benign skin lesion removal procedures effective immediately (August 2025). Claims must now be billed with specific diagnosis code groupings—Group 1 requires a single listed diagnosis, Group 2 requires diagnoses from both Column A and Column B, and Group 3 (malignant diagnoses) applies only to CPT 11300-11313. Claims submitted without proper diagnosis code pairing will be denied as not medically necessary.
High impact
Special Alert October 2025 - Neuraxial Labor Analgesia/Anesthesia
Providence Health Plan·Effective Dec 1, 2025
Effective 12/1/2025, Providence Health Plan will cap reimbursement for neuraxial labor analgesia/anesthesia (CPT 01967) at 480 units (480 minutes) for all non-Medicaid lines of business. Any units billed in excess of this 480-unit cap will be denied. Billing teams must implement system edits to prevent claim denials.
Medium impact
Special Alert October 2025 - Electrolysis Documentation Requirements
Providence Health Plan·Effective Dec 1, 2025
Effective 12/1/2025, Providence Health Plan now requires specific clinical documentation for all electrolysis claims related to gender affirmation services on Commercial and Medicare lines of business. Documentation must include diagnosis of gender incongruence/dysphoria, WPATH SOC-8 alignment statement, clinical rationale, detailed treatment plan with session counts, and treatment area descriptions. This requirement does NOT apply to Providence OHP members.
High impact
Special Alert November 2025 - 2026 Outpatient Site of Service
Providence Health Plan·Effective Jan 1, 2026
Effective January 1, 2026, Providence Health Plan (Commercial Fully Insured only) now requires prior authorization to verify medical necessity before performing hernia repairs and laparoscopic cholecystectomies at hospital outpatient facilities (place of service 22). If medical criteria are not met, these procedures must be performed at an ambulatory surgery center (ASC) instead, or coverage will be denied. The policy also removes prolonged surgery (>3 hours) as a qualifying reason for hospital outpatient use.

Browse by payer Browse by state Browse by specialty Browse by billing code Browse & filter all changes

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert

Archive by year

2023 2024 2025 2026

Tzield® (Teplizumab-Mzwv)

Synagis ® (Palivizumab)

Scenesse® (Afamelanotide)

Saphnelo® (Anifrolumab-Fnia)

Kebilidi® (Eladocagene Exuparvovec-Tneq)

Itvisma® (Onasemnogene Abeparvovec-Brve)

Intracanalicular and Intravitreal Corticosteroid Implants

Clotting Factors, Coagulant Blood Products, & Other Hemostatics

Adzynma (ADAMTS13, Recombinant-Krhn)

Surgery of the Wrist or Thumb

Surgery of the Elbow

Spinal Fusion and Decompression

Skin and Soft Tissue Substitutes

Sinus Surgeries and Interventions

Screening Colonoscopy Procedures – Site of Service

Outpatient Surgical Procedures – Site of Service

Molecular Oncology Testing for Solid Tumor Cancer Diagnosis, Prognosis, and Treatment Decisions

Gender Dysphoria Treatment

Cognitive Rehabilitation and Coma Stimulation

Brow Ptosis and Eyelid Repair

Physical and Occupational Therapy Coverage for Adults in a Clinic Setting

Special Alert August 2025 - Benign Skin Lesion Removal Billing Guidelines

Special Alert October 2025 - Neuraxial Labor Analgesia/Anesthesia

Special Alert October 2025 - Electrolysis Documentation Requirements

Special Alert November 2025 - 2026 Outpatient Site of Service